Filed with the SEC on · Summarized by InvestorsBot
Pablo J. Cagnoni, Incyte’s President and Global Head of R&D, sold 10,640 shares of common stock at $122.69 per share on Aug. 5, 2026. The transaction was valued at approximately $1,305,422, leaving him with 204,804 shares.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeIncyte Reaches CMS Agreement on Medicaid Pricing for Jakafi and Jakafi XR
8-K · August 31, 2026
Incyte R&D chief sells $1.36 million in stock
Form 4 · Insider Trade · August 20, 2026
Incyte R&D chief sells 10,803 shares for about $1.3 million
Form 4 · Insider Trade · August 14, 2026
Incyte EVP Patrick Mayes sells $5.7M in stock
Form 4 · Insider Trade · August 4, 2026
Incyte R&D chief sells $1.9 million in stock
Form 4 · Insider Trade · August 4, 2026
Incyte reports Q2 revenue growth and raises 2026 sales guidance
8-K · July 28, 2026